Skip to content
Description
The ALMAG-03 Diamag is a non-invasive transcranial magnetic stimulation device that uses pulsed magnetic fields to treat various neurological conditions including Parkinson's disease, migraines, and post-stroke effects.
Treatments typically run 7-20 days with daily sessions that can be repeated after 1-2 months. While designed for home use without medical training, it's contraindicated for people with conditions like tuberculosis, severe heart disease, bleeding disorders, pacemakers, or pregnancy.
Clinical studies support its safety and effectiveness, and it comes with a full guarantee from Almagia International.
Key Details
-
Non-Invasive Treatment: ALMAG-03 offers a pain-free option to stimulate brain activity without surgery, using magnetic fields to affect nerve cells.
-
Easy to Use: This device is user-friendly, equipped with straightforward instructions, making it accessible for home use without needing medical expertise.
-
Versatile Applications: Designed to address conditions like migraines, Parkinson’s disease, and post-stroke recovery, ALMAG-03 serves a wide range of neurological needs.
-
Programmable Treatment Sessions: With specific programs for different conditions, ALMAG-03 allows for personalized treatment, adjustable in duration and frequency according to patient needs.
-
Safety and Contraindications: It comes with clear guidelines on who should not use it, ensuring patient safety by outlining specific health conditions that warrant caution.
-
Backed by Research: The effectiveness of ALMAG-03 is supported by clinical trials, ensuring its reliability and performance in therapeutic settings.
- Manufacturer’s Guarantee: ALMAG-03 is guaranteed by Almagia International, promising quality service and maintenance for the device.
Specifications
| Type of Device | Transcranial Magnetic Stimulation (TMS) |
| Treatment Method | Non-invasive, using pulsed magnetic fields |
| Indications | Suitable for treating migraines, chronic iridocyclitis, Parkinson’s disease, post-stroke symptoms, and other neurological conditions |
| Treatment Programs | Multiple, including specific settings for different conditions |
| Session Duration | Typically 7-10 days for initial program, with a maximum of 20 consecutive days of treatment |
| Treatment Frequency | Once per day, with courses repeatable after 1.5 to 2 months |
| Contraindications | Not suitable for people with certain conditions like active tuberculosis, severe respiratory or heart diseases, bleeding disorders, pacemakers, or pregnancy |
| Service and Warranty | Provided by Almagia International, including full guarantee and maintenance support |